United States · FDA National Drug Code directory
Envarsus XR
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68992-3010_163c129d-f4e2-484d-af96-c265c9a5e38c
- Product NDC
- 68992-3010
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Tacrolimus
- Labeler
- Veloxis Pharmaceuticals, Inc
- Marketing category
- NDA
- Marketing start / end (source format)
- 20150901
- Source listing expiry
- 20261231
Source-listed ingredients
- TACROLIMUS — 1 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 POUCH in 1 CARTON (68992-3010-1) / 1 BOTTLE in 1 POUCH / 100 TABLET, EXTENDED RELEASE in 1 BOTTLE · 68992-3010-1
- 1 POUCH in 1 CARTON (68992-3010-3) / 1 BOTTLE, PLASTIC in 1 POUCH / 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC · 68992-3010-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →